
Emily Leproust
@emilyleproust
Entrepreneur & CEO @TwistBioscience. Fascinated by #synbio and #genetics
ID: 1141698938
http://www.twistbioscience.com 02-02-2013 06:46:35
3,3K Tweet
13,13K Followers
294 Following

I love it when accurate science is shared widely—let's make sure it outshines misinformation! W. Ian Lipkin of ColumbiaPublicHealth sets the record straight about childhood vaccines is this fantastic article. Please share these facts with your network! thehill.com/opinion/health…



Huge congratulations to David Baker, Demis Hassabis and John Jumper for their Nobel win! Working with Institute for Protein Design has been an absolute pleasure, and we could be more thrilled. Well deserved! 🧬 washingtonpost.com/science/2024/1…


We 💚 iGEM Headquarters! Thanks to all who came out for Emily Leproust’s keynote: “Pushing the Boundaries of Synthetic Biology: How Current Advancements Will Help You Shape the Future.” iGEM Community #iGEM2024 #GrandJamboree #WorldExpoSynbio


Happy IPO anniversary to Twist Bioscience! Ringing that bell was exciting and the momentum continues to grow! 🧬 #WeMakeDNA

Things in biotechnology that just make sense: the pairing of Twist Bioscience and @Absci, & AI + DNA! Alex Philippidis of Genetic Engineering & Biotechnology News recently spoke with Twist CEO Emily Price Leproust & Absci CEO Sean McClain about the partnership👇 bit.ly/3YGGQmi




New and very important preprint from notable industry leaders on AI and nuclei acid screening! Congratulations to Eric Horvitz, and all the authors at Microsoft Research, Aclid, and EBRC, including Twist Bioscience’s James Diggans.


Emily Leproust Twist Bioscience CEO confirmed for SynBioBeta 2025! Her DNA synthesis tech is literally rewriting the future of bio. Catch her game-changing insights May 5-8 in San Jose. Complete list of speakers found here: bit.ly/4eGqMYn #SyntheticBiology


In 2024, for the first time, we worked on a collaborative group project on phage therapy where Massachusetts Institute of Technology (MIT), Harvard University, and global students designed their own lysis proteins. Twist Bioscience synthesized their DNA designs and we expressed the proteins via Nuclera digital microfluidics:

DNA offers a long term, stable, eco-friendly, & relevant solution to the data storage crunch. “The goal is to write DNA at terrific speeds and on a vast scale.” Emily Leproust Read more about DNA data storage in this The New Yorker piece by Matthew Hutson buff.ly/7o8xwOW

🎉 We are excited to announce our collaboration with Curio Genomics to accelerate the adoption of NGS workflows in agrigenomics by offering Twist’s FlexPrep™ Ultra-High Throughput Library Prep Kit with Curio’s bioinformatics software & data platform! 👉 tinyurl.com/3mjdvk9w


Congratulations to our CEO and co-founder Emily Leproust for being awarded one of the Top 100 Biotech Leaders In The World! 🎉 👉 buff.ly/TCjEwOt


🥳 It’s our 12th birthday! 🥳 Twelve years ago, we set out to revolutionize synthetic biology with our groundbreaking DNA synthesis technology. Today, we're proud to be empowering customers across healthcare, agriculture, data storage, and beyond. 🧬 Twist Bioscience


Get ready for Hyperscale Biology! SynBioBeta kicks off next week in San Jose — it's a who’s who of AI and bio. Synthetic biology is here, and it’s reshaping trillion-dollar industries. This is where the future is being built, so don't miss it: syntheticbiologysummit.com

🧬 Happy 25th anniversary to the Human Genome Project!! 🎉 In this Genetic Engineering & Biotechnology News article, leading scientists including our own Emily Leproust, reflect on the acceleration in genomics, innovations in diagnostics & therapeutics & more— made possible by the HGP! buff.ly/7Kq0Ck2